← All Amedisys INC filings

Amedisys INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

AMED
Amedisys INC
10-K/A: Amedisys Files Amendment No. 2 to Form 10-K for Fiscal Year Ended December 31, 2024, Addressing Part III Information
Amedisys files Amendment No. 2 to its Form 10-K to include information required by Part III and updated certifications from the CEO and CFO.
AMED
Amedisys INC
10-K/A: Amedisys Corrects Share Count in Amended 10-K Filing
Amedisys files an amendment to its 2024 Annual Report to correct the number of outstanding shares of common stock as of February 21, 2025.
AMED
Amedisys INC
10-K: Amedisys Reports 2024 Results Amidst Pending Merger with UnitedHealth Group
Amedisys files its 2024 10-K, detailing financial performance and ongoing merger uncertainties with UnitedHealth Group.
AMED
Amedisys INC
10-K/A: Amedisys Files Amended 10-K Report, Details Executive Compensation and Governance
Amedisys has filed an amendment to its annual report on Form 10-K, primarily to include information required by Part III of the form, focusing on executive compensation, corporate governance, and related matters.
AMED
Amedisys INC
10-K: Amedisys Accelerates Executive Payments and Vesting Ahead of UnitedHealth Merger
Amedisys is accelerating bonus payments and equity vesting for executives as part of a 280G mitigation strategy ahead of its merger with UnitedHealth Group.